Yoshihiro Inamoto - Concepedia

Author

Yoshihiro Inamoto

Also Known As

Battiwalla, Minoo, Hikaru Kobayashi, Horowitz, Mary M., Inamoto, Yoshihiro, Jagasia, Madan H., Naoki Kurita, Peter Garred, Pidala, J., Pidala, Joseph, Y Inamoto

391

Publications

15.1K

Citations

H-Index

106

Concepts

All Affiliations

Fred Hutch Cancer Center Medical College of Wisconsin Vanderbilt University Medical Center Moffitt Cancer Center Dana-Farber Cancer Institute

About

Yoshihiro Inamoto is an author at Fred Hutch Cancer Center specializing in medicine, transplantation, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	55	7.2K
2	Health Sciences	13	17	460
3	Public Health	3	3	77
4	Nursing	1	1	46
5	Biomedical Engineering	1	1	15

Yoshihiro Inamoto

152

Publications

13.4K

Citations

H-Index

Page 1

	Year	Citations
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report Madan Jagasia, Hildegard Greinix, Mukta Arora, Biology of Blood and Marrow Transplantation Solid Organ TransplantationImmunologyPathologySurgeryChronic Gvhd	2014	5.2K
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria Mary E.D. Flowers, Yoshihiro Inamoto, Paul A. Carpenter, Blood	2011	668
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research Sally Arai, Mukta Arora, Tao Wang, Biology of Blood and Marrow Transplantation	2014	429
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report Stephanie J. Lee, Daniel Wolff, Carrie L. Kitko, Biology of Blood and Marrow Transplantation	2015	402
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation Joseph Pidala, Stephanie J. Lee, Kwang Woo Ahn, Blood	2014	274
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation Kirsten M. Williams, Guang‐Shing Cheng, Iskra Pusic, Biology of Blood and Marrow Transplantation	2015	205
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI Edward A. Copelan, Betty K. Hamilton, Belinda R. Avalos, Blood	2013	182
Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Mukta Arora, Corey Cutler, Madan Jagasia, Biology of Blood and Marrow Transplantation	2015	172
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, Ernesto Ayala, Transplantation and Cellular Therapy	2021	165
Failure-free survival after initial systemic treatment of chronic graft-versus-host disease Yoshihiro Inamoto, Mary E.D. Flowers, Brenda M. Sandmaier, Blood	2014	132

Page 1